
Integration of Functional Human Auditory Neural Circuits Based on a 3D Carbon Nanotube System
Brief intro:
- Author: Yiyun Lou, Jiaoyao Ma, Yangnan Hu, Xiaoying Yao, Yaoqian Liu, Mingxuan Wu, Gaogan Jia, Yan Chen, Renjie Chai, Mingyu Xia, Wenyan Li
- Journal: Advanced Science
- Doi: https://www.doi.org/10.1002/advs.202309617
- Publication Date: 2024 Jul 18
Products/Services used in the paper
Quotation shows PackGene:The virus used for this study were AAV2/DJ-CMV-mCherry (Obio Technology Corp) and AAV2/9-hSyn-EGFP (PackGene Biotech). Viral titer ≥ 1E+13 GC mL−1.
Research Field:peripheral and central auditory systems
AAV Serotype:AAV2
Targeted organ:incubation
Animal or cell line strain:SGN and ACN Single Cells
Abstract
The physiological interactions between the peripheral and central auditory systems are crucial for auditory information transmission and perception, while reliable models for auditory neural circuits are currently lacking. To address this issue, mouse and human neural pathways are generated by utilizing a carbon nanotube nanofiber system. The super-aligned pattern of the scaffold renders the axons of the bipolar and multipolar neurons extending in a parallel direction. In addition, the electrical conductivity of the scaffold maintains the electrophysiological activity of the primary mouse auditory neurons. The mouse and human primary neurons from peripheral and central auditory units in the system are then co-cultured and showed that the two kinds of neurons form synaptic connections. Moreover, neural progenitor cells of the cochlea and auditory cortex are derived from human embryos to generate region-specific organoids and these organoids are assembled in the nanofiber-combined 3D system. Using optogenetic stimulation, calcium imaging, and electrophysiological recording, it is revealed that functional synaptic connections are formed between peripheral neurons and central neurons, as evidenced by calcium spiking and postsynaptic currents. The auditory circuit model will enable the study of the auditory neural pathway and advance the search for treatment strategies for disorders of neuronal connectivity in sensorineural hearing loss.
About PackGene
PackGene Biotech is a world-leading CRO and CDMO, excelling in AAV vectors, mRNA, plasmid DNA, and lentiviral vector solutions. Our comprehensive offerings span from vector design and construction to AAV, lentivirus, and mRNA services. With a sharp focus on early-stage drug discovery, preclinical development, and cell and gene therapy trials, we deliver cost-effective, dependable, and scalable production solutions. Leveraging our groundbreaking π-alpha 293 AAV high-yield platform, we amplify AAV production by up to 10-fold, yielding up to 1e+17vg per batch to meet diverse commercial and clinical project needs. Moreover, our tailored mRNA and LNP products and services cater to every stage of drug and vaccine development, from research to GMP production, providing a seamless, end-to-end solution.
